Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

ClinicalTrials.gov ID: NCT05010577

Public ClinicalTrials.gov record NCT05010577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection

Study identification

NCT ID: NCT05010577
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: BiomX, Inc.; Industry
Enrollment: 43 participants

Conditions and interventions

Conditions

Interventions

BX004-A Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 20, 2022
Primary completion: Mar 9, 2024
Completion: Mar 9, 2024
Last update posted: Jul 17, 2025

2022 – 2024

United States locations

U.S. sites: 18
U.S. states: 14
U.S. cities: 18

Facility	City	State	ZIP	Site status
The University of Alabama at Birmingham	Birmingham	Alabama	35294	—
Providence Alaska Medical Center	Anchorage	Alaska	99508	—
University of Arkansas for Medical Sciences	Little Rock	Arkansas	72205	—
Yale University	New Haven	Connecticut	06519	—
Children's National Medical Center	Washington D.C.	District of Columbia	20010	—
University of Florida	Gainesville	Florida	32608	—
Joe DiMaggio Children's Hospital	Hollywood	Florida	33021	—
Central Florida Pulmonary Group	Orlando	Florida	32803	—
Boston Children's Hospital	Boston	Massachusetts	02130	—
New York Medical College	Valhalla	New York	10595	—
Cincinnati Children's Hospital	Cincinnati	Ohio	45229	—
University Hospitals Rainbow Babies and Children's Hospital	Cleveland	Ohio	44106	—
Nationwide Children's Hospital	Columbus	Ohio	43205	—
Penn State Health Milton S. Hershey Medical Center	Hershey	Pennsylvania	17033	—
Medical University of South Carolina	Charleston	South Carolina	29425	—
Baylor College of Medicine, Texas Children Clinic	Houston	Texas	77030	—
University of Utah	Salt Lake City	Utah	84132	—
Seattle Children's Hospital	Seattle	Washington	98105	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05010577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 17, 2025 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05010577 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →